98%
921
2 minutes
20
This study investigated the association of Mediterranean diet (MED) adherence with chronic constipation and chronic diarrhea, using a nationally representative sample of U.S. adults. This cross-sectional study analyzed 11,612 participants from the 2005 to 2010 National Health and Nutrition Examination Survey (NHANES). Adherence to MED was assessed through the alternative Mediterranean diet (aMED) index. Bowel habits were categorized using the Bristol Stool Form Scale (BSFS), with chronic constipation defined as BSFS types 1-2, and chronic diarrhea as types 6-7, based on the usual or most common stool type reported by participants. Multivariate logistic regression models and subgroup analyses were employed to assess associations of MED adherence with chronic constipation and chronic diarrhea. Restricted cubic spline analyses were conducted to explore potential nonlinear relationships. Higher aMED scores were associated with a lower likelihood of chronic constipation (OR: 0.82, 95% CI: 0.75, 0.89). Participants in the highest aMED category had 43% lower odds of chronic constipation compared to those in the lowest category (OR: 0.57, 95% CI: 0.43, 0.75). Subgroup analysis indicated that this association was strongest among obese individuals (BMI ≥ 30 kg/m) (OR: 0.69, 95% CI: 0.58, 0.82). No significant associations were observed between aMED scores and chronic diarrhea in the fully adjusted model. Adherence to the Mediterranean diet was significantly associated with lower prevalence of chronic constipation but showed no significant relationship with chronic diarrhea in the U.S. population. Further longitudinal research is needed to clarify causality and explore population-specific effects.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12351127 | PMC |
http://dx.doi.org/10.1002/fsn3.70809 | DOI Listing |
Clin Transl Gastroenterol
September 2025
Lynda K and David M Underwood Center for Digestive Health, Houston Methodist, Houston, TX, USA.
Introduction: Pharmacological therapies for chronic idiopathic constipation (CIC) are useful, but many patients report dissatisfaction from a lack of efficacy and occurrence of adverse events. The vibrating capsule (VC) is an FDA approved non-pharmacologic, treatment for CIC. However, its long-term usefulness in a community setting is unknown.
View Article and Find Full Text PDFNeurotrauma Rep
August 2025
Population Health and Optimal Practices Research Unit (Trauma-Emergency-Critical Care Medicine), CHU de Québec-Université Laval Research Center, Québec City, Canada.
Pain is prevalent and a major source of disability after a traumatic brain injury (TBI) and a spinal cord injury (SCI). With a view of reducing the pain burden in neurotrauma, this study aimed to describe the use of pain management strategies and the adverse effects of opioids in patients with TBI and SCI. We collected data at hospital discharge (T1) and at 3 months post-injury (T2).
View Article and Find Full Text PDFFront Med (Lausanne)
August 2025
Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chronic intestinal pseudo-obstruction (CIPO) is a rare and severe intestinal motility disorder with poor long-term prognosis and high mortality rate, especially when the small intestine is involved. Due to the non-specificity of clinical symptoms, CIPO has long faced diagnostic challenges. With the advancements of sequencing technology, many hereditary CIPOs have been identified.
View Article and Find Full Text PDFMicrobiol Res
September 2025
Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, Tianjin, China. Electronic address:
Intractable functional constipation (IFC), a severe form of chronic constipation characterized by slow transit and resistance to conventional treatments, posed a significant clinical challenge. Here, we identified Lactococcus formosensis (Lf), a Gram-positive bacterium prevalent in IFC patients, as a novel contributor to intestinal motility impairment. Clinically, IFC patients exhibited increased colonic mucosal colonization of Lf and significant myenteric neuronal loss and pyroptosis, particularly in excitatory choline acetyltransferase (ChAT) neurons, but not inhibitory neuronal nitric oxide synthase (nNOS) neurons.
View Article and Find Full Text PDFEndocrinol Diabetes Metab Case Rep
July 2025
Department of Internal Medicine, Medical City Arlington, Arlington, Texas, USA.
Summary: Hypercalcemia is a prevalent electrolyte disturbance commonly associated with primary hyperparathyroidism, cancer, or medication adverse effects. Thiazide diuretics reduce urinary calcium excretion, increasing calcium reabsorption and hypercalcemia. Tirzepatide, a dual GIP and GLP-1 receptor agonist, is increasingly used for type 2 diabetes and obesity.
View Article and Find Full Text PDF